Status:
COMPLETED
OatMeal and Insulin Resistance: OMA-IR
Lead Sponsor:
Universitätsmedizin Mannheim
Conditions:
Diabetes Mellitus Type 2
Insulin Resistance
Eligibility:
All Genders
18-80 years
Phase:
PHASE3
Brief Summary
Insulin resistance is a central feature of Diabetes mellitus type 2 (Stumvoll et al. 2005). Hypo- and hyperglycemic states are associated with adverse inpatient outcomes (ADA et al. 2006 Diab Care) an...
Eligibility Criteria
Inclusion
- diabetes mellitus 2
- insulin therapy
- stable therapy modality within the last 3 months
- deteriorated glucose metabolism (Hba1c \> 7%)
- insulin resistance, defined as more than 1 unit of insulin per kg and day
Exclusion
- acute vascular event within the last 3 months
- planed weight reducing therapy
- acute and chronic inflammatory disease
- therapy with corticosteroids
- pregnancy
Key Trial Info
Start Date :
January 1 2007
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
February 1 2010
Estimated Enrollment :
15 Patients enrolled
Trial Details
Trial ID
NCT00401453
Start Date
January 1 2007
End Date
February 1 2010
Last Update
February 17 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Fifth Medical Clinic
Mannheim, Baden-Wurttemberg, Germany, 68167